Furthermore, we examined the mRNA levels of six signatures in mouse liver and showed that Ramp3, S100a9, Sapcd2, Spp1 and Csad were exhibited at higher levels in the NAFLD group compared to NC group (Figs. 8G–8I, 8K, 8L). This evidence concerns the gene S100A9 and metabolic dysfunction-associated steatotic liver disease.